BRABEC, Tomas, Matouš VOBOŘIL, Dagmar SCHIEROVA, Evgeny VALTER, Iva SPLICHALOVA, Jan DOBEŠ, Jiri BREZINA, Martina DOBESOVA, Aigerim AIDAROVA, Martin JAKUBEC, Jasper MANNING, Richard BLUMBERG, Ari WAISSMAN, Michal KOLAR, Jan KUBOVCIAK, Dagmar SRUTKOVA, Tomas HUDCOVIC, Martin SCHWARZER, Eva FRONKOVA, Tereza PINKASOVÁ, Petr JABANDŽIEV and Dominik FILIPP. IL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum. Mucosal Immunology. NEW YORK: ELSEVIER SCIENCE INC, 2023, vol. 16, No 4, p. 373-385. ISSN 1933-0219. Available from: https://dx.doi.org/10.1016/j.mucimm.2023.01.005.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name IL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum
Authors BRABEC, Tomas (203 Czech Republic), Matouš VOBOŘIL (203 Czech Republic), Dagmar SCHIEROVA (203 Czech Republic), Evgeny VALTER (203 Czech Republic), Iva SPLICHALOVA (203 Czech Republic), Jan DOBEŠ (203 Czech Republic), Jiri BREZINA (203 Czech Republic), Martina DOBESOVA (203 Czech Republic), Aigerim AIDAROVA (203 Czech Republic), Martin JAKUBEC (203 Czech Republic), Jasper MANNING (203 Czech Republic), Richard BLUMBERG (203 Czech Republic), Ari WAISSMAN (203 Czech Republic), Michal KOLAR (203 Czech Republic), Jan KUBOVCIAK (203 Czech Republic), Dagmar SRUTKOVA (203 Czech Republic), Tomas HUDCOVIC (203 Czech Republic), Martin SCHWARZER (203 Czech Republic), Eva FRONKOVA (203 Czech Republic), Tereza PINKASOVÁ (203 Czech Republic, belonging to the institution), Petr JABANDŽIEV (203 Czech Republic, belonging to the institution) and Dominik FILIPP (203 Czech Republic, guarantor).
Edition Mucosal Immunology, NEW YORK, ELSEVIER SCIENCE INC, 2023, 1933-0219.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.000 in 2022
RIV identification code RIV/00216224:14110/23:00130512
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.mucimm.2023.01.005
UT WoS 001066088900001
Keywords in English Paneth cells; IL-17 Signaling; Antimicrobial peptides; Crohn's disease; ileal microbiota
Tags 14110317, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/1/2024 08:02.
Abstract
IL-17 protects epithelial barriers by inducing the secretion of antimicrobial peptides (AMPs). However, the effect of IL-17 on Paneth cells (PCs), the major producers of AMPs in the small intestine, is unclear. Here, we show that targeted ablation of the IL-17 receptor (IL-17R) in PCs disrupts their antimicrobial functions and decreases the frequency of ileal PCs. These changes become more pronounced after colonization with IL-17 inducing segmented filamentous bacteria (SFB). Mice with PCs that lack IL-17R show an increased inflammatory transcriptional profile in the ileum along with the severity of experimentally induced ileitis. These changes are associated with a decrease in the diversity of gut microbiota that induces a severe ileum pathology upon transfer to genetically susceptible mice which can be prevented by the systemic administration of IL–17a/f in microbiota recipients. In an exploratory analysis of a small cohort of pediatric patients with Crohn’s disease, we have found that a portion of these patients exhibit a low number of lysozyme-expressing ileal PCs and a high ileitis severity score, resembling the phenotype of mice with IL-17R-deficient PCs. Our study identifies IL–17R-dependent signaling in PCs as an important mechanism that maintains ileal homeostasis through the prevention of dysbiosis.
PrintDisplayed: 22/6/2024 18:37